Literature DB >> 15221103

[Diabetes mellitus needs unrestricted evaluation of patient data to yield treatment progress. The DUTY Register].

W Krone1, M Böhm.   

Abstract

Patients with diabetes mellitus require consistent risk management that fulfills risk reduction guidelines for patients suffering from CHD (coronary heart disease). The aim of the DUTY Registry (diabetes mellitus needs unrestricted evaluation of patient data to yield treatment progress) was to show whether the guidelines of the Deutsche Diabetes-Gesellschaft (DDG) are incorporated consistently into daily practice. Therefore 59,035 patients suffering from diabetes mellitus type 1 and type 2 were examined by general practitioners. The physician was requested to enter 20 consecutive patients with existing or newly diagnosed diabetes mellitus into the registry. A total of 45,605 patients showed up for the final examination after 9 months. The results presented show that too many patients suffering from diabetes mellitus do not receive consistent therapy for cardiovascular risk factors according to guidelines and therefore the required target values were rarely reached.

Entities:  

Mesh:

Year:  2004        PMID: 15221103     DOI: 10.1007/s00103-004-0843-2

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  7 in total

1.  [External control in medicine. Sense or nonsense].

Authors:  M Weber; O Zierenberg
Journal:  Internist (Berl)       Date:  2007-06       Impact factor: 0.743

2.  Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline.

Authors:  Peter Bramlage; Christiane Binz; Anselm K Gitt; Michael Krekler; Tanja Plate; Evelin Deeg; Diethelm Tschöpe
Journal:  Cardiovasc Diabetol       Date:  2010-09-16       Impact factor: 9.951

Review 3.  Stroke risk screening of adults with hypertension: prospective cross-sectional study in primary care.

Authors:  Kurt Bestehorn; Klaus Wahle; W Kirch
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

4.  Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry.

Authors:  Roland E Schmieder; Anselm K Gitt; Cornelia Koch; Peter Bramlage; Taoufik Ouarrak; Diethelm Tschöpe
Journal:  BMC Endocr Disord       Date:  2015-05-02       Impact factor: 2.763

5.  Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUE.

Authors:  Anselm K Gitt; Roland E Schmieder; Eva Duetting; Peter Bramlage; Steffen Schneider; Diethelm Tschöpe
Journal:  Cardiovasc Diabetol       Date:  2012-12-05       Impact factor: 9.951

6.  Patterns and predictors of statin prescription in patients with type 2 diabetes.

Authors:  Heiner K Berthold; Ioanna Gouni-Berthold; Michael Böhm; Wilhelm Krone; Kurt P Bestehorn
Journal:  Cardiovasc Diabetol       Date:  2009-05-13       Impact factor: 9.951

7.  Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry.

Authors:  Kurt Bestehorn; Christina Jannowitz; Barbara Karmann; David Pittrow; Wilhelm Kirch
Journal:  BMC Public Health       Date:  2009-08-04       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.